These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 19143880)

  • 21. [Valproate-associated hyperammonemic encephalopathy. Report of one case].
    Young P; Finn BC; Alvarez F; Bruetman JE; Trimarchi H
    Rev Med Chil; 2007 Nov; 135(11):1446-9. PubMed ID: 18259656
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Serum sickness induced by rituximab infusion; report of two cases with hematological malignancies].
    Matsui T; Hidaka M; Kawakita T; Inoue Y; Sakai T; Harada N; Takemoto S; Nagakura S; Tsukamoto A; Kiyokawa T; Kawano F
    Rinsho Ketsueki; 2009 Apr; 50(4):304-8. PubMed ID: 19404025
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Acute hyperammonemic encephalopathy in a non-cirrhotic patient with hepatocellular carcinoma reversed by arginine therapy.
    Shinde SS; Sharma P; Davis MP
    J Pain Symptom Manage; 2014 Apr; 47(4):e5-7. PubMed ID: 24731681
    [No Abstract]   [Full Text] [Related]  

  • 24. Interstitial pneumonitis and alveolar hemorrhage complicating use of rituximab: case report and review of the literature.
    Heresi GA; Farver CF; Stoller JK
    Respiration; 2008; 76(4):449-53. PubMed ID: 17596682
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Depletion of B lymphocytes from cerebral perivascular spaces by rituximab.
    Martin Mdel P; Cravens PD; Winger R; Kieseier BC; Cepok S; Eagar TN; Zamvil SS; Weber MS; Frohman EM; Kleinschmidt-Demasters BK; Montine TJ; Hemmer B; Marra CM; Stüve O
    Arch Neurol; 2009 Aug; 66(8):1016-20. PubMed ID: 19667224
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Further Concerns About Glutamine: A Case Report on Hyperammonemic Encephalopathy.
    Cioccari L; Gautschi M; Etter R; Weck A; Takala J
    Crit Care Med; 2015 Oct; 43(10):e458-60. PubMed ID: 26035146
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Idiopathic hyperammonemia (IHA) after dose-dense induction chemotherapy for acute myeloid leukemia: Case report and review of the literature.
    Metzeler KH; Boeck S; Christ B; Hausmann A; Stemmler HJ; Parhofer KG; Ostermann H; Hiddemann W; Braess J
    Leuk Res; 2009 Jul; 33(7):e69-72. PubMed ID: 19230970
    [No Abstract]   [Full Text] [Related]  

  • 28. An 18-year-old woman with hyperammonemia.
    Sehli S; Nugent KM; Samathanam CA; Alalawi R
    Chest; 2009 Mar; 135(3):869-871. PubMed ID: 19265098
    [No Abstract]   [Full Text] [Related]  

  • 29. Metabolic encephalopathy: neurologic and psychiatric considerations.
    Aring CD
    Heart Lung; 1982; 11(6):516-21. PubMed ID: 6922851
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pegylated asparaginase as cause of fatal hyperammonemia in patients with latent urea cycle disorder.
    Peters M; Zee-Cheng J; Kuhl A; Orozco J; Lally E; Schwoerer JS
    Pediatr Blood Cancer; 2018 Sep; 65(9):e27239. PubMed ID: 29775236
    [No Abstract]   [Full Text] [Related]  

  • 31. An imaging-based rapid evaluation method for complement-dependent cytotoxicity discriminated clinical response to rituximab-containing chemotherapy.
    Mishima Y; Sugimura N; Matsumoto-Mishima Y; Terui Y; Takeuchi K; Asai S; Ennishi D; Asai H; Yokoyama M; Kojima K; Hatake K
    Clin Cancer Res; 2009 May; 15(10):3624-32. PubMed ID: 19417028
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Interstitial pneumonitis as a side effect of rituximab].
    Kemming JL; van Zeeland RE; Ullmann EF; Mattijssen EJ
    Ned Tijdschr Geneeskd; 2009; 153():A526. PubMed ID: 19785875
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hyperammonemic encephalopathy precipitated by a bleeding peptic ulcer.
    Gaur S; Shukla V
    South Med J; 2003 Jan; 96(1):106. PubMed ID: 12602737
    [No Abstract]   [Full Text] [Related]  

  • 34. Rapid infusion rituximab changing practice for patient care.
    Al Zahrani A; Ibrahim N; Al Eid A
    J Oncol Pharm Pract; 2009 Sep; 15(3):183-6. PubMed ID: 19171551
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Isolated hyperammonemic encephalopathy in heart transplantation.
    Madathil RJ; Gilstrap LG; Pelletier MP; Mehra MR
    J Heart Lung Transplant; 2018 Mar; 37(3):427-429. PubMed ID: 29275142
    [No Abstract]   [Full Text] [Related]  

  • 36. [Valproate-induced hyperammonemic encephalopathy. Review of cases in the psychiatric setting].
    Fassi G; Igoa A; Liste OA
    Vertex; 2008; 19(82):371-7. PubMed ID: 19424520
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hyperammonemic coma presenting as Hashimoto's encephalopathy.
    Adatia S; Poladia B; Joshi SR; Panikar V; Chauhan V; Hastak SM
    J Assoc Physicians India; 2008 Dec; 56():989-91. PubMed ID: 19322981
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tumor lysis syndrome occurring after the administration of rituximab for posttransplant lymphoproliferative disorder.
    Francescone SA; Murphy B; Fallon JT; Hammond K; Pinney S
    Transplant Proc; 2009 Jun; 41(5):1946-8. PubMed ID: 19545762
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Metabolic encephalopathy caused by nitrous oxide ('laughing gas') induced hyperammonaemia.
    Vive MGD; Anguelova GV; Duim S; Hofstee HMA
    BMJ Case Rep; 2019 Nov; 12(11):. PubMed ID: 31772134
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intestinal perforation associated with rituximab therapy for post-transplant lymphoproliferative disorder after liver transplantation.
    Cornejo A; Bohnenblust M; Harris C; Abrahamian GA
    Cancer Chemother Pharmacol; 2009 Sep; 64(4):857-60. PubMed ID: 19588139
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.